Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population

被引：0
|
作者：
Jeffrey S. Berger
Veronica Ashton
François Laliberté
Guillaume Germain
Brahim Bookhart
Dominique Lejeune
Julien Boudreau
Patrick Lefebvre
Matthew R. Weir
机构：
[1] New York University School of Medicine,
[2] Janssen Scientific Affairs,undefined
[3] LLC,undefined
[4] Groupe d’analyse,undefined
[5] Ltée,undefined
[6] University of Maryland School of Medicine,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Diabetes; Healthcare costs; Healthcare resource utilization; Non-valvular atrial fibrillation; Real-world; Rivaroxaban; Warfarin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1224 / 1241
页数：17
相关论文
共 50 条
  • [1] Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population
    Berger, Jeffrey S.
    Ashton, Veronica
    Laliberte, Francois
    Germain, Guillaume
    Bookhart, Brahim
    Lejeune, Dominique
    Boudreau, Julien
    Lefebvre, Patrick
    Weir, Matthew R.
    [J]. ADVANCES IN THERAPY, 2023, 40 (03) : 1224 - 1241
  • [2] Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population
    Berger, Jeffrey S.
    Laliberte, Francois
    Kharat, Akshay
    Lejeune, Dominique
    Moore, Kenneth Todd
    Jung, Young
    Lefebvre, Patrick
    Ashton, Veronica
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 550 - 562
  • [3] Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Diabetes
    Matthew R. Weir
    Yen-Wen Chen
    Jinghua He
    Brahim Bookhart
    Alicia Campbell
    Veronica Ashton
    [J]. Diabetes Therapy, 2021, 12 : 3167 - 3186
  • [4] Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Diabetes
    Weir, Matthew R.
    Chen, Yen-Wen
    He, Jinghua
    Bookhart, Brahim
    Campbell, Alicia
    Ashton, Veronica
    [J]. DIABETES THERAPY, 2021, 12 (12) : 3167 - 3186
  • [5] Healthcare Costs Before and After Stroke in Non-Valvular Atrial Fibrillation (NVAF) Patients Who Initiated Treatment With Rivaroxaban or Warfarin
    Milentijevic, Dejan
    Lin, Jennifer H.
    Wang, Kun
    Bisht, Deepti
    Kogan, Emily
    Twyman, Kathryn
    Alberts, Mark
    [J]. STROKE, 2019, 50
  • [6] Total Healthcare Costs Before and After Stroke in Non-Valvular Atrial Fibrillation (NVAF) Patients Who Initiated Treatment With Rivaroxaban or Warfarin
    Lin, Jennifer H.
    Milentijevic, Dejan
    Shrivastava, Shubham
    Kogan, Emily
    Sjoeland, Erik
    Alberts, Mark
    [J]. STROKE, 2020, 51
  • [7] Rivaroxaban versus Warfarin: Effect on Healthcare Resource Utilization and Costs in Nonvalvular Atrial Fibrillation Patients
    Laliberte, Francois
    Crivera, Concetta
    Nelson, Winnie W.
    Olson, William H.
    Schein, Jeffrey
    Germain, Guillaume
    Lefebvre, Patrick
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 480 - 481
  • [8] Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation
    Nelson, Winnie W.
    Song, Xue
    Coleman, Craig I.
    Thomson, Erin
    Smith, David M.
    Damaraju, C. V.
    Schein, Jeffrey R.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (12) : 2461 - 2469
  • [9] Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population
    Berger, Jeffrey S.
    Laliberte, Francois
    Kharat, Akshay
    Lejeune, Dominique
    Moore, Kenneth Todd
    Jung, Young
    Lefebvre, Patrick
    Ashton, Veronica
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (06) : 881 - 890
  • [10] Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?
    Laliberte, Francois
    Pilon, Dominic
    Raut, Monika K.
    Nelson, Winnie W.
    Olson, William H.
    Germain, Guillaume
    Schein, Jeff R.
    Lefebvre, Patrick
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (08) : 1521 - 1528
12345